The article discusses the emerging field of AI-driven phage therapy, highlighting its potential to combat antibiotic-resistant bacteria. It explores the mechanisms through which bacteriophages can be engineered to target specific pathogens, offering a promising alternative to traditional antibiotics. The implications for public health and future research directions are also considered.